Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut de Recherches Internationales Servier

Criteria

Inclusion Criteria:

• systolic congestive heart failure

• sinus rhythm, HR >= 80bpm

Exclusion Criteria:

• unstable cardiovascular condition